The role of the MAPK pathway alterations in GM-CSF modulated human neutrophil apoptosis with aging.
BACKGROUND: Neutrophils represent the first line of defence against aggressions. The programmed death of neutrophils is delayed by pro-inflammatory stimuli to ensure a proper resolution of the inflammation in time and place. The pro-inflammatory stimuli include granulocyte-macrophage colony-stimulating factor (GM-CSF). Recently, we have demonstrated that although neutrophils have an identical spontaneous apoptosis in elderly subjects compared to that in young subjects, the GM-CSF-induced delayed apoptosis is markedly diminished. The present study investigates whether an alteration of the GM-CSF stimulation of MAPKs play a role in the diminished rescue from apoptosis of PMN of elderly subjects. METHODS: Neutrophils were separated from healthy young and elderly donors satisfying the SENIEUR protocol. Neutrophils were stimulated with GM-CSF and inhibitors of the MAPKinase pathway. Apoptosis commitment, phosphorylation of signaling molecules, caspase-3 activities as well as expression of pro- and anti-apoptotic molecules were performed in this study. Data were analyzed using Student's two-tailed t-test for independent means. Significance was set for p </= 0.05 unless stated otherwise. RESULTS: In this paper we present evidence that an alteration in the p42/p44 MAPK activation occurs in PMN of elderly subjects under GM-CSF stimulation and this plays a role in the decreased delay of apoptosis of PMN in elderly. We also show that p38 MAPK does not play a role in GM-CSF delayed apoptosis in PMN of any age-groups, while it participates to the spontaneous apoptosis. Our results also show that the alteration of the p42/p44 MAPK activation contributes to the inability of GM-CSF to decrease the caspase-3 activation in PMN of elderly subjects. Moreover, GM-CSF converts the pro-apoptotic phenotype to an anti-apoptotic phenotype by modulating the bcl-2 family members Bax and Bcl-xL in PMN of young subjects, while this does not occur in PMN of elderly. However, this modulation seems MAPK independent. CONCLUSION: Our results show that the alteration of p42/p44 MAPK activation contributes to the GM-CSF induced decreased PMN rescue from apoptosis in elderly subjects. The modulation of MAPK activation in PMN of elderly subjects might help to restore the functionality of PMN with aging.
Larbi
Anis
A
Laboratory of Immunology, Research Center on Aging, University of Sherbrooke, Qc, Canada. tamas.fulop@usherbrooke.ca.
Douziech
Nadine
N
Fortin
Carl
C
Linteau
Annie
A
Dupuis
Gilles
G
Fulop
Tamas
T
Drugs Aging. 2005;22(7):589-603
16038574
Surgery. 1999 Aug;126(2):406-12
10455914
Clin Infect Dis. 2000 Aug;31(2):578-85
10987724
Mech Ageing Dev. 2003 Apr;124(4):419-25
12714248
J Biol Chem. 2001 Jan 19;276(3):2189-99
11053415
Eur J Clin Invest. 2004 Jan;34(1):50-6
14984438
Atherosclerosis. 2001 May;156(1):11-21
11368992
Am J Respir Cell Mol Biol. 2002 Nov;27(5):561-7
12397015
Blood. 1992 Oct 15;80(8):2012-20
1382715
Blood. 1998 Sep 15;92(6):1989-2002
9731057
Arch Immunol Ther Exp (Warsz). 2003;51(1):1-8
12691299
Nihon Rinsho. 1999 Sep;57 Suppl:524-6
10543168
Nature. 1988 Aug 25;334(6184):715-8
2842685
Adv Immunol. 2002;80:243-84
12078483
Blood. 1999 May 1;93(9):3106-15
10216108
J Biol Chem. 1999 Oct 22;274(43):31108-13
10521512
Lancet Infect Dis. 2002 Nov;2(11):659-66
12409046
J Leukoc Biol. 2004 Aug;76(2):291-9
15039467
J Clin Invest. 1989 Mar;83(3):865-75
2921324
J Biol Chem. 2003 Aug 1;278(31):28443-54
12736263
Mech Ageing Dev. 1997 Jun;96(1-3):15-34
9223108
Am J Physiol Cell Physiol. 2004 Nov;287(5):C1264-72
15229106
J Biol Chem. 1998 Apr 3;273(14):8389-97
9525949
J Immunol. 2000 Apr 15;164(8):4286-91
10754327
J Leukoc Biol. 2004 Feb;75(2):373-81
14657209
J Exp Med. 1996 Aug 1;184(2):429-40
8760796
J Biol Chem. 1998 Jan 9;273(2):1058-63
9422769
Shock. 2002 Nov;18(5):401-6
12412617
Surgery. 2001 Aug;130(2):242-8
11490356
Cell Signal. 1998 Oct;10(9):619-28
9794243
J Immunol. 1999 Feb 1;162(3):1692-700
9973431
Eur J Immunol. 1997 Dec;27(12):3536-9
9464845
Exp Cell Res. 2000 Apr 10;256(1):34-41
10739649
N Engl J Med. 2000 Aug 3;343(5):338-44
10922424
J Biol Chem. 2004 Feb 13;279(7):5947-57
14612448
Microbios. 2001;106(414):129-36
11506063
J Biol Chem. 1995 Mar 31;270(13):7420-6
7535770
FEBS Lett. 2001 Jan 5;487(3):318-22
11163351
Mech Ageing Dev. 1990 Jul;55(1):89-105
2205767
Blood. 1998 Dec 15;92(12):4808-18
9845548
Immunol Rev. 2003 Jun;193:101-10
12752675
Aging Cell. 2004 Aug;3(4):217-26
15268755
J Clin Immunol. 1998 Sep;18(5):321-9
9793824
Ann N Y Acad Sci. 2002 Nov;973:305-8
12485884